Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage
J K
JK
North Hampshire Hospital, Aldermaston Road, Basingstoke, Hants, UK. johnramage1@compuserve.com
Davies
A H G
AH
Ardill
J
J
Bax
N
N
Caplin
M
M
Grossman
A
A
Hawkins
R
R
McNicol
A M
AM
Reed
N
N
Sutton
R
R
Thakker
R
R
Aylwin
S
S
Breen
D
D
Britton
K
K
Buchanan
K
K
Corrie
P
P
Gillams
A
A
Lewington
V
V
McCance
D
D
Meeran
K
K
Watkinson
A
A
D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D002985:Clinical Protocols; D003952:Diagnostic Imaging / Q000379:methods; D004621:Embolization, Therapeutic / Q000379:methods; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009362:Neoplasm Metastasis / Q000175:diagnosis / Q000628:therapy; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D011788:Quality of Life; D013048:Specimen Handling; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents